ACT
Device
Uromedica, Incorporated
Total Payments
$59,360
Transactions
9
Doctors
2
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $11,075 | 2 | 0 |
| 2022 | $18,944 | 2 | 0 |
| 2021 | $29,341 | 5 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $53,377 | 6 | 89.9% |
| Honoraria | $5,000 | 1 | 8.4% |
| Travel and Lodging | $983.00 | 2 | 1.7% |
Payments by Type
Research
$53,377
6 transactions
General
$5,983
3 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Adjustable Continence Therapy (ACT) for the Treatment of Female SUI | Uromedica, Incorporated | $53,377 | 0 |
Ad
Manufacturing Companies
- Uromedica, Incorporated $59,360
Product Information
- Type Device
- Total Payments $59,360
- Total Doctors 2
- Transactions 9
About ACT
ACT is a device associated with $59,360 in payments to 2 healthcare providers, recorded across 9 transactions in the CMS Open Payments database. The primary manufacturer is Uromedica, Incorporated.
Payment data is available from 2021 to 2023. In 2023, $11,075 was paid across 2 transactions to 0 doctors.
The most common payment nature for ACT is "Unspecified" ($53,377, 89.9% of total).
ACT is associated with 1 research study, including "Adjustable Continence Therapy (ACT) for the Treatment of Female SUI" ($53,377).